Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06654466 · ClinicalTrials.gov registry record · NA
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
A NA study of Hereditary Cancer Syndromes and Clinical Decision Support, sponsored by Nest Genomics.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06654466 is a NA study of Hereditary Cancer Syndromes and Clinical Decision Support that is actively recruiting participants, run by Nest Genomics. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06654466, a NA study of Hereditary Cancer Syndromes and Clinical Decision Support, is actively recruiting participants, sponsored by Nest Genomics.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to see if a software platform can improve cancer screening in young adults with genetic risk for cancer. The trial will also help improve the software platform (Nest). The main questions it aims to answer are: * Do Nest users know more about their cancer risks and recommended care than non-users? * Do Nest users have less psychological distress than non-users? * Do Nest users share cancer risks with family and other doctors more than non-users? * Are Nest users more likely than non-users to have up-to-date care plans? Researchers will compare Nest users to non-users to see if the Nest users are more likely to do recommended cancer screening. Participants will: * Have a genetic counseling or follow up visit * Take a post-visit survey * Intervention arm only: use the Nest Patient Navigator * Complete screening and follow-up care recommended by doctors
Conditions Studied
Interventions
- DEVICE Nest, an electronic medical record (EMR)-integrated software platform to deliver longitudinal, genetics-based care at scale.
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-02-10 |
| Est. Completion | 2027-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06654466
The ClinicalTrials.gov registry entry for NCT06654466 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nest Genomics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hereditary Cancer Syndromes appearing as the primary indexed condition, and to 1 intervention - of which Nest, an electronic medical record (EMR)-integrated software platform to deliver longitudinal, genetics-based care at scale. is the first listed.
NCT06654466 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06654466 about?
NCT06654466 is a clinical study titled "Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer". The goal of this clinical trial is to see if a software platform can improve cancer screening in young adults with genetic risk for cancer. The trial will also help improve the software platform (Nest). The main questions it aims to answer are: * Do Nest users know more about their cancer risks an...
What is the current status of trial NCT06654466?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-02-10. Estimated completion is 2027-09.
What conditions does trial NCT06654466 study?
This clinical trial studies the following conditions: Hereditary Cancer Syndromes, Clinical Decision Support.
What interventions are being tested in trial NCT06654466?
The interventions under investigation include: Nest, an electronic medical record (EMR)-integrated software platform to deliver longitudinal, genetics-based care at scale. (DEVICE).
Who is sponsoring clinical trial NCT06654466?
This trial is sponsored by Nest Genomics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06654466 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hereditary Cancer Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Hereditary Cancer Syndromes
All registered trials for this condition
Clinical Decision Support
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.